ns 1619 has been researched along with casein kinase ii in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, KW; Kim, CD; Kim, KY; Lee, JH; Lee, WS; Rhim, BY; Shin, HK; Shin, YW | 1 |
1 other study(ies) available for ns 1619 and casein kinase ii
| Article | Year |
|---|---|
Cilostazol enhances casein kinase 2 phosphorylation and suppresses tumor necrosis factor-alpha-induced increased phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and apoptotic cell death in SK-N-SH cells.
Topics: Apoptosis; Benzimidazoles; Casein Kinase II; Cell Death; Chromosomes, Human, Pair 10; Cilostazol; Cyclic AMP Response Element-Binding Protein; Humans; Indoles; Microfilament Proteins; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Tensins; Tetrazoles; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins; Vasodilator Agents | 2004 |